# Atovaquone Oral Suspension

NDC: 10702-223
Generic name: Atovaquone
Labeler / Manufacturer: KVK-Tech, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: SUSPENSION
Routes: ORAL
Marketing started: 20190329

FDA application: ANDA210510

## Active ingredients

- ATOVAQUONE: 750 mg/5mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"10702-223"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=10702-223
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b31ff20a-c363-4be0-9bc0-3081c163b63c